BioPartners.ch
Title
Welcome to biopartners
Description
About Us
Since its inception in 2000, Biopartners has become a leader in the development of biosimilars. It also focuses on the development of innovative, patentable formulations of first-generation biopharmaceuticals with significant market potential, such as sustained release formulations of existing products in such indications as oncology, haematology, nephrology, endocrinology, virology and CNS. From the patient point of view, second generation biopharmaceutical similars may potentially offer both increased compliance and better treatment of existing conditions, as well as for new indications. Patients and healthcare providers may also benefit from increased price competitiveness. Biopartners works closely with other leading experts and suppliers in the field, to accelerate product development through all stages right up to market launch. This approach has successfully generated a strong pipeline in:
from the European Commission, the daily release biosimilar formulation of recombinant Human Growth Hormone. With its Head Office located in Switzerland, and an affiliate located in Germany, Biopartners has developed an international network which operates through a series of collaborations and partnerships with leading outsourcing and distribution companies.
Languages
English
